- Home
- ZURA vs JG Comparison
ZURA vs JG Comparison
Compare ZURA & JG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZURA
- JG
- Stock Information
- Founded
- ZURA 2022
- JG 2012
- Country
- ZURA United States
- JG China
- Employees
- ZURA N/A
- JG N/A
- Industry
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- JG Computer Software: Programming Data Processing
- Sector
- ZURA Health Care
- JG Technology
- Exchange
- ZURA Nasdaq
- JG Nasdaq
- Market Cap
- ZURA 69.9M
- JG 64.1M
- IPO Year
- ZURA N/A
- JG 2018
- Fundamental
- Price
- ZURA $1.30
- JG $11.88
- Analyst Decision
- ZURA Buy
- JG
- Analyst Count
- ZURA 7
- JG 0
- Target Price
- ZURA $14.33
- JG N/A
- AVG Volume (30 Days)
- ZURA 689.3K
- JG 25.0K
- Earning Date
- ZURA 08-08-2025
- JG 08-28-2025
- Dividend Yield
- ZURA N/A
- JG N/A
- EPS Growth
- ZURA N/A
- JG N/A
- EPS
- ZURA N/A
- JG N/A
- Revenue
- ZURA N/A
- JG $46,938,193.00
- Revenue This Year
- ZURA N/A
- JG $10.90
- Revenue Next Year
- ZURA N/A
- JG N/A
- P/E Ratio
- ZURA N/A
- JG N/A
- Revenue Growth
- ZURA N/A
- JG 17.73
- 52 Week Low
- ZURA $0.97
- JG $2.36
- 52 Week High
- ZURA $5.07
- JG $20.94
- Technical
- Relative Strength Index (RSI)
- ZURA 58.73
- JG 60.24
- Support Level
- ZURA $1.00
- JG $10.86
- Resistance Level
- ZURA $1.45
- JG $12.52
- Average True Range (ATR)
- ZURA 0.10
- JG 0.89
- MACD
- ZURA 0.02
- JG 0.03
- Stochastic Oscillator
- ZURA 66.67
- JG 63.00
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About JG Aurora Mobile Limited
Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates and generates its revenue from the People's Republic of China.